Steven Kaufman
Chief Strategy Officer

Combination Product Solutions

Is this your profile?

About

Steven Kaufman is a distinguished executive in the drug delivery industry with more than 21 years of experience delivering innovative solutions to pharmaceutical and biotechnology companies. He is the Executive Director of Combination Product Solutions, as well as serving as Portal Instruments’ Chief Commercial Officer and Eco-inject’s Chief Strategy Officer, bringing extensive expertise in combination products and self-injection technologies.

Before setting up Combination Product Solutions in January 2023, Mr Kaufman held executive leadership positions in strategy, marketing and business development at several industry-recognised organisations, including Stevanato Group, Bespak and SHL Medical.

Contributions

Interview: Eco-Inject: Bringing Affordable Sustainability to Single-Use Disposable Autoinjectors

In this exclusive interview, Michael Earl and Steven Kaufman speak about the significant progress Eco-Inject has made throughout 2026 since its highly successful funding round earlier in the year, discussing what’s new in the world of Eco-Inject, what sets the device platform apart from other approaches to sustainability in the autoinjector space, and how the industry is reacting to Eco-Inject as it moves towards the market.

More contributions

Sustainability, Balancing Priorities, and Bringing New Solutions to Market

Steven Kaufman discusses the return of sustainability to the centre of drug delivery conversation and how Eco-Inject's novel autoinjector brings fresh thinking to the sector.

Interview: Steven Kaufman. Delivering the Future – Inside the World of Autoinjector Innovation

Steven Kaufman talks with ONdrugDelivery’s Guy Furness about the world of autoinjectors, looking at the current status quo in the industry, using Portal’s PRIME Nexus™ smart reusable electromechanical autoinjector as a lens to bring into focus how things have changed and where they might be going.

#133_May_2022_OM_Fig2

INTERVIEW: STEVEN KAUFMAN, STEVANATO GROUP, & MICHAEL EARL, OWEN MUMFORD

In this exclusive interview, Steven Kaufman of Stevanato Group, and Michael Earl of Owen Mumford, talked with us about their companies' recent major agreement for the manufacturing and provision of prefillable syringes for the advanced two-step, single-use autoinjector, Aidaptus^®.

INDUSTRIALISATION

LEVERAGING INTEGRATION THROUGHOUT A DRUG DELIVERY SYSTEM PROJECT

Steven Kaufman and Adam Stops describe how an integrated offering can help customers at each phase of a drug delivery system project.

INTERVIEW WITH STEVEN KAUFMAN, STEVANATO & URI BARUCH, CDP

Steven Kaufman and Uri Baruch discuss the recently announced collaboration between their two companies to accelerate the development of a new variable-dose, cartridge-based pen injector platform for diabetes.

CAN WEARABLE DEVICES BRIDGE THE GAP BETWEEN PEN INJECTOR AND PUMP?

Steven Kaufman and Paolo Golfetto explore the potential for wearable injectors to be disruptive technologies in the drug delivery market.

STEVEN R KAUFMAN, BESPAK

Steven Kaufman is Global Business Development Lead at Bespak Europe Ltd, responsible for business development activities related to injectable devices such as auto-injectors and wearable injection systems.

PREFILLED SYRINGES

OVERCOMING THE CHALLENGES: COMBINING INJECTABLE DRUG WITH SELF-INJECTION DEVICE

Steven Kaufman talks about a broad range of challenges that biopharmaceutical companies and their partners will likely face on the road to taking their biologics, biosimilars, generic injectables and even biobetters to market in combination products.

Top